Reduce falls by improving balance
- Trial ID
- NCT06598891
- Official Title
- Effect of Combined PAS Balance Training on Individuals With PD
- Goal
- Reduce falls by improving balance
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Chang Gung University
- Study Type
- INTERVENTIONAL
- Enrollment
- 60 participants
- Conditions
- PD - Parkinson's Disease
- Interventions
- Weight shift training and APA feedback, Paired associative stimulation
Plain-Language Summary
The goal is to improve balance by strengthening the anticipatory postural adjustments that help you shift weight quickly and avoid trips or falls. The approach pairs guided weight-shift training with real-time APA feedback, alongside paired associative stimulation, a noninvasive method that times mild peripheral nerve pulses with magnetic stimulation of the motor cortex to strengthen brain-to-muscle connections and boost learning from the training. Because it is a non-drug intervention, it does not change how levodopa works and is meant to complement your usual medications, not replace them. The study is looking for about 60 adults aged 20 and up with a clinical Parkinson disease diagnosis, excluding people with leg musculoskeletal injuries, osteoporosis, or other peripheral or central nervous system conditions.
Locations
- Chang Gung University, Taoyuan District, Taiwan
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Weight shift training and APA feedback. The goal is to improve balance by strengthening the anticipatory postural adjustments that help you shift weight quickly and avoid trips or falls. The approach pairs guided weight-shift training with real-time APA feedback, alongside paired associative stimulation, a noninvasive method that times mild peripheral nerve pulses with magnetic stimulation of the motor cortex to strengthen brain-to-muscle connections and boost learning from the training. Because it is a non-drug intervention, it does not change how levodopa works and is meant to complement your usual medications, not replace them. The study is looking for about 60 adults aged 20 and up with a clinical Parkinson disease diagnosis, excluding people with leg musculoskeletal injuries, osteoporosis, or other peripheral or central nervous system conditions.
- Who can participate?
- Participants must be at least 20 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 7 months.